Moderna says its revised flu shot succeeds against all 4 strains of the virus

Moderna flu shot succeeds in late-stage study Moderna on Wednesday said its flu vaccine had generated a stronger immune response against all four A and B strains of the influenza virus compared to traditional flu shots in a late-stage trial, sending shares up about 6% in early trading. Patrick Wingrove Reuters

...

Moderna could use this data to file for accelerated approval of its flu shot in the United States by year-end, and likely launch the vaccine by the 2024/2025 season, Jefferies analyst Michael Yee said in a note.

...